Literature DB >> 26838584

Reversible growth failure and complete GH deficiency in a 4-year-old girl with very early Hashimoto's thyroiditis and subsequent hyperplasia of pituitary thyrotroph cells.

Laura Gaspari1,2,3, Françoise Paris2,3, Nicolas Leboucq4, Alain Bonafé4, Charles Sultan5,6.   

Abstract

UNLABELLED: Hashimoto's thyroiditis is a well-known cause of growth retardation in adolescence. It is less frequently seen in children and rarely seen in infants. A 4-year-old girl was referred to our clinic for a second opinion before starting growth hormone (GH) treatment. Linear growth had markedly declined in the past 2 years, with height -3.4 standard deviations. GH deficiency was complete. She had dry, gray-sallow skin and bloated abdomen, but no goiter. The parents reported fatigue and constipation. Hormonal evaluation revealed TSH 629.5 mIU/ml, free T4 0.08 ng/dl, and prolactin 17.2 ng/ml. Bone age was 2 years. Antibodies to thyroglobulin and thyroid peroxidase were positive, suggesting Hashimoto's thyroiditis. Brain magnetic resonance imaging showed anterior pituitary hyperplasia. After 3 years of L-thyroxine therapy, she was symptomless, her height was -0.6 standard deviations, and the TSH level was normal. Brain magnetic resonance imaging showed regression of the pituitary hyperplasia.
CONCLUSIONS: This report describes a patient with Hashimoto's thyroiditis and pituitary hyperplasia, both quite rare in very young children. Acquired hypothyroidism may appear after neonatal screening and therefore should not be overlooked in investigations of short stature, even when clinical signs of hypothyroidism are absent. WHAT IS KNOWN: • Hashimoto's thyroiditis and pituitary hyperplasia are rare in very young children. • Acquired hypothyroidism can appear after negative neonatal screening and should not be overlooked. What is New: • Short children should be evaluated for growth hormone deficiency but only after excluding other causes, particularly hypothyroidism, as we report a child with this disease but no clinical signs of it.

Entities:  

Keywords:  Growth hormone deficiency; Hypothyroidism; Pituitary hyperplasia

Mesh:

Substances:

Year:  2016        PMID: 26838584     DOI: 10.1007/s00431-016-2698-6

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  9 in total

1.  Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society.

Authors: 
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

2.  Iodine intake and prevalence of thyroid autoimmunity and autoimmune thyroiditis in children and adolescents aged between 1 and 16 years.

Authors:  Emilio García-García; María Ángeles Vázquez-López; Eduardo García-Fuentes; Firma Isabel Rodríguez-Sánchez; Francisco Javier Muñoz; Antonio Bonillo-Perales; Federico Soriguer
Journal:  Eur J Endocrinol       Date:  2012-06-22       Impact factor: 6.664

3.  Reversible suprasellar pituitary mass secondary to hypothyroidism.

Authors:  J A Atchison; P A Lee; A L Albright
Journal:  JAMA       Date:  1989-12-08       Impact factor: 56.272

4.  Increased familial clustering of autoimmune thyroid diseases.

Authors:  M Dittmar; C Libich; T Brenzel; G J Kahaly
Journal:  Horm Metab Res       Date:  2011-02-01       Impact factor: 2.936

5.  Effect of thyroid hormone and growth hormone on recovery from hypothyroidism of epiphyseal growth plate cartilage and its adjacent bone.

Authors:  D Lewinson; Z Harel; P Shenzer; M Silbermann; Z Hochberg
Journal:  Endocrinology       Date:  1989-02       Impact factor: 4.736

6.  Pituitary hyperplasia resulting from primary hypothyroidism mimicking macroadenomas.

Authors:  M Young; K Kattner; K Gupta
Journal:  Br J Neurosurg       Date:  1999-04       Impact factor: 1.596

Review 7.  Influence of thyroid hormones on the regulation of growth hormone secretion.

Authors:  A Giustina; W B Wehrenberg
Journal:  Eur J Endocrinol       Date:  1995-12       Impact factor: 6.664

Review 8.  Pituitary hyperplasia secondary to primary hypothyroidism: a case report and review of the literature.

Authors:  Ami Sharad Joshi; Paul D Woolf
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

9.  Gene expression of hypothalamic somatostatin, growth hormone releasing factor, and their pituitary receptors in hypothyroidism.

Authors:  S P Tam; K S Lam; G Srivastava
Journal:  Endocrinology       Date:  1996-02       Impact factor: 4.736

  9 in total
  3 in total

Review 1.  Pituitary hyperplasia in childhood primary hypothyroidism: a review.

Authors:  Shabal Sapkota; Mitesh Karn; Sulav Sapkota
Journal:  Childs Nerv Syst       Date:  2021-01-06       Impact factor: 1.475

Review 2.  Thyroid hormone therapy in congenital hypothyroidism and pediatric hypothyroidism.

Authors:  Andrew J Bauer; Ari J Wassner
Journal:  Endocrine       Date:  2019-07-26       Impact factor: 3.633

3.  Effects of recombinant human growth hormone in the treatment of dwarfism and relationship between IGF-1, IGFBP-3 and thyroid hormone.

Authors:  Shanxiang Ren; Yuxiang Nie; Aihong Wang
Journal:  Exp Ther Med       Date:  2016-10-21       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.